Serum Hormone Concentrations in Transgender Individuals Receiving Gender-Affirming Hormone Therapy: A Longitudinal Retrospective Cohort Study
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 27 (1), 27-33
- https://doi.org/10.4158/ep-2020-0414
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R21HD076387, UL1TR002378)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 34 references indexed in Scilit:
- Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a reviewAndrologia, 2013
- Men and women, so different, so similar: observations from cross-sex hormone treatment of transsexual subjectsAndrologia, 2013
- Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual PersonsThe Journal of Sexual Medicine, 2012
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7International Journal of Transgenderism, 2012
- Care of Transsexual PersonsThe New England Journal of Medicine, 2011
- The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapyJournal of Thrombosis and Haemostasis, 2010
- Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta‐analysesClinical Endocrinology, 2009
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2009
- Review of Studies of Androgen Treatment of Female-to-Male Transsexuals: Effects and Risks of Administration of Androgens to FemalesThe Journal of Sexual Medicine, 2008
- A comparison of androgen production and clearance in hirsute and obese womenJournal of Steroid Biochemistry, 1983